Breast Neoplasms Clinical Trial
— BE3Official title:
Assessment of ShearWave™ Elastography in the Ultrasonic Diagnosis of Breast Cancer in Chinese Patients
| NCT number | NCT02226081 |
| Other study ID # | BE3 |
| Secondary ID | ChiCTR-DDT-14004 |
| Status | Completed |
| Phase | |
| First received | |
| Last updated | |
| Start date | June 2014 |
| Est. completion date | June 2015 |
| Verified date | December 2018 |
| Source | SuperSonic Imagine |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
We aim to determine if adding ShearWave Elastography to a standard ultrasound breast exam can improve the characterization (classification) of breast lesions.
| Status | Completed |
| Enrollment | 2273 |
| Est. completion date | June 2015 |
| Est. primary completion date | June 2015 |
| Accepts healthy volunteers | No |
| Gender | Female |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - female - 18 years of age or older - known breast lesion that has not been managed or treated - referred for a breast ultrasound because of a breast mass found on at least one of the following examinations: - physical palpation - mammography - ultrasound exam - MRI Exclusion Criteria: - Women who are unwilling or unable to provide informed consent - Women with breast implants - Women who are pregnant or breastfeeding - Women in whom all lesions are diagnostically categorized as BI-RADS 0, 1 or 6 - Women with previous ipsilateral breast surgery - Women with no visible breast mass on ultrasound examination - Women with axillary metastatic lymph nodes only - Women with foreign body in the breast - Women who are not Chinese nationality |
| Country | Name | City | State |
|---|---|---|---|
| China | 1st Affiliated Hospital of PLAGH (304) | Beijing | |
| China | Beijing Friendship Hospital, Capital Medical University | Beijing | |
| China | People's Liberation Army General Hospital (301) | Beijing | |
| China | Affiliated Hospital of Binzhou Medical University | Binzhou | |
| China | Sichuan Provincial People's Hospital | Chengdu | |
| China | West China Hospital, Sichuan University | Chengdu | |
| China | Fujian Provincial Cancer Hospital | Fuzhou | |
| China | Guangdong Provincial Traditional Chinese Medical Hospital | Guangzhou | |
| China | Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University | Guangzhou | |
| China | Sun-Yat Sen University Cancer Center | Guangzhou | |
| China | 1st Affiliated Hospital of Harbin University | Harbin | |
| China | Hefei 2nd People's Hospital | Hefei | |
| China | Jiangsu Provincial Hospital | Nanjing | |
| China | Yinzhou People's Hospital | Ningbo | |
| China | Fudan University Cancer Center | Shanghai | |
| China | 1st Affiliated Hospital of China Medical University | Shenyang | |
| China | 4th Affiliated Hospital of China Medical University | Shenyang | |
| China | Shengjing Hospital of China Medical University | Shenyang | |
| China | General Hospital of TISCO | Taiyuan | |
| China | Shanxi Dayi Hospital | Taiyuan | |
| China | 1st Affiliated Hospital of Xi'an Jiaotong University | Xi'an | |
| China | 1st Affiliated Hospital of Zhengzhou University | Zhengzhou |
| Lead Sponsor | Collaborator |
|---|---|
| SuperSonic Imagine |
China,
Lin X, Chang C, Wu C, Chen Q, Peng Y, Luo B, Tang L, Li J, Zheng J, Zhou R, Cui G, Li A, Wang X, Qian L, Zhang J, Wen C, Gay J, Zhang H, Li A, Chen Y. Confirmed value of shear wave elastography for ultrasound characterization of breast masses using a cons — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Increase in specificity of breast ultrasound imaging when considering stiffness measurements | Within 18 months of the study start date | ||
| Secondary | Change of sensitivity and negative predictive value of breast ultrasound imaging when considering stiffness measurements | Within 18 months of the study start date | ||
| Secondary | Increase in positive predictive value for biopsy of breast ultrasound when considering stiffness measurements | within 18 months of the study start date |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Enrolling by invitation |
NCT05558917 -
Comparison Between PECS BLOCK 2 vs ESP BLOCK in Ocnologic Breast Surgery
|
N/A | |
| Active, not recruiting |
NCT03664778 -
Abbreviated Breast MRI After Cancer Treatment
|
||
| Recruiting |
NCT03144622 -
18F-FSPG PET/CT Imaging in Patients With Cancers
|
||
| Completed |
NCT05452499 -
Pain Neuroscience Education and Therapeutic Exercise as a Treatment for Breast Cancer Survivors Living With Sequelae
|
N/A | |
| Active, not recruiting |
NCT04568902 -
Study of H3B-6545 in Japanese Women With Estrogen Receptor (ER)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer
|
Phase 1 | |
| Completed |
NCT02860585 -
Evaluation of Survival in Patients With Metastatic Breast Cancer Receiving High-dose Chemotherapy With Autologous Haematopoietic Stem Cell Transplantation
|
N/A | |
| Completed |
NCT04059809 -
Photobiomodulation for Breast Cancer Radiodermatitis
|
Phase 2/Phase 3 | |
| Recruiting |
NCT04557449 -
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
|
Phase 1/Phase 2 | |
| Completed |
NCT03698942 -
Delphinus SoftVue™ ROC Reader Study
|
||
| Completed |
NCT00092950 -
Exercise in Women at Risk for Breast Cancer
|
Phase 2 | |
| Terminated |
NCT04123704 -
Sitravatinib in Metastatic Breast Cancer
|
Phase 2 | |
| Not yet recruiting |
NCT02151071 -
The Breast Surgery EnLight and LightPath Imaging System Study
|
Phase 1/Phase 2 | |
| Recruiting |
NCT02934360 -
TR(ACE) Assay Clinical Specimen Study
|
N/A | |
| Active, not recruiting |
NCT02950064 -
A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA Mutations
|
Phase 1 | |
| Completed |
NCT02931552 -
Nuevo Amanecer II: Translating a Stress Management Program for Latinas
|
N/A | |
| Not yet recruiting |
NCT02876848 -
A Novel E-Health Approach in Optimizing Treatment for Seniors (OPTIMUM Study)
|
N/A | |
| Recruiting |
NCT02547545 -
Breast Cancer Chemotherapy Risk Prediction Mathematical Model
|
N/A | |
| Completed |
NCT02303366 -
Pilot Study of Stereotactic Ablation for Oligometastatic Breast Neoplasia in Combination With the Anti-PD-1 Antibody MK-3475
|
Phase 1 | |
| Completed |
NCT02652975 -
Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium
|
N/A | |
| Completed |
NCT02518477 -
Preventive Intervention Against Lymphedema After Breast Cancer Surgery
|
N/A |